Adaptive Biotechnologies (ADPT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. The adaptive immune system is a force inside your body so powerful it’s able to detect disease and fight it, often before you even realize that you’re sick. Adaptive Biotechnologies transforms data stream into new immune medicine platform with Azure "We use Azure cloud computing resources and machine learning capabilities to power our immune medicine platform, so we can rapidly map the adaptive immune system to the many different diseases it recognizes. Adaptive Biotechnologies is harnessing this vast system of biology to unleash its power as a natural diagnostic and therapeutic tool to propel a paradigm shift in medicine. Source: Adaptive Biotechnologies (ADPT) More ADPT News. Coronavirus (COVID-19) Update: FDA Authorizes Adaptive Biotechnologies T-Detect COVID Test. Consumer Marketing, T-Detect at Adaptive Biotechnologies Corp. Evans School of Public Policy and Governance, University of Washington View profile View profile badges Welcome to the Diagnostic Portal! Working at Adaptive Biotechnologies | Glassdoor Manufacturing Audio, Video Mounts & Rigging for over 30 Years. Adaptive Biotechnologies was founded on the premise that if you could read how the adaptive immune system detects and treats disease, you could harness these natural abilities to make a difference in the ... Mission: Our mission is to translate the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. To be part of that change, we are looking for the people who take chances, who carve unconventional paths, and people who can read the stories that have yet to be written. Julie Rubinstein, C’93, W’93, came to Penn with a plan to enter medical school.At the time, Wharton was pioneering in studies of healthcare systems, and she discovered an interest in this field. SEATTLE--(BUSINESS WIRE)-- Adaptive Biotechnologies an immune-driven medicine company, today announced that it will enter into a worldwide collaboration and license agreement with Genentech, a member of the Roche Group, to develop, manufacture and commercialize novel neoantigen directed T-cell therapies for the treatment of a broad range of … It harnesses the inherent biology of the adaptive immune system to … A biotechnology company using the inherent biology of the adaptive immune system to advance the diagnosis and treatment of disease. Agena Bioscience, Inc. … Mr. Goel ADPT stock SEC Form 4 insiders trading. Adaptive Biotechnologies Corporation is a commercial-stage company. To be part of that change, we are looking for the people who take chances, who carve unconventional paths, and people who can read the stories that have yet to be written. In March, Adaptive Biotechnologies extended its collaboration with Microsoft to study the immune response to SARS-CoV-2, the virus that causes COVID-19. In April, it entered into an agreement with Amgen to develop potential antibody therapies for COVID-19. Passive Bookrunner, July 2020. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . ... Adaptive Biotechnologies is a commercial-stage biotech company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Adaptive Biotechnologies is an Equal Opportunity Employer. See what people working for Adaptive Biotechnologies are saying. SEATTLE, Wa., January 4, 2019 – Adaptive Biotechnologies, an immune-driven medicine company, today announced that it will enter into a worldwide collaboration and license agreement with Genentech, a member of the Roche Group, to develop, manufacture and commercialize novel neoantigen directed T-cell therapies for the treatment of a broad range of cancers. Adaptive Biotechnologies Corporation is a commercial-stage company. Earlier this year, an enthusiastic market more than doubled the price of Adaptive Biotechnologies stock. Now that shares are trading around 22% below their recent peak, investors are wondering if it's a good time to buy. Image source: Getty Images. There are plenty of good reasons to buy Adaptive Biotechnologies. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. What is it like to work at Adaptive Biotechnologies? Get … David has made over 6 trades of the Adaptive Biotechnologies stock since 2014, according to the Form 4 filled with the SEC. Adaptive is advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Company Information. Image: Primary Logo . Adaptive Biotechnologies Corp. Sep 2014 - Apr 20161 year 8 months. Adaptive Biotechnologies. The estimated Net Worth of Julie Rubinstein is at least $2.77 Million dollars as of 1 March 2021. Adaptive Biotechnologies Corporation was founded in 2009 and is headquartered in Seattle, Washington. Adaptive Technologies Group manufactures audio speaker mounts and rigging, led and lcd video mounts and rigging, cinema surround sound mounts, projector lifts and enclosures for the pro av industry. Adaptive Biotechnologies Corporation is a commercial-stage company. The Seattle biotech company Adaptive Biotechnologies has started research on a coronavirus therapeutic that could halt the spread of the virus. Adaptive is making plans for a massive expansion. Adaptive Biotechnologies Corp. Aethlon Medical. Adaptive Biotechnologies Corporation is a commercial-stage company. Founded in 2009 by two young Fred Hutch researchers — computational biologist Harlan Robins and molecular biologist and geneticist Chris Carlson — Adaptive Biotechnologies has quickly become a leader in high-throughput DNA sequencing of immune system T cells and B cells for research and diagnostic purposes. ADAPTIVE MEDIA Beth Keshishian 917-912-7195 media@adaptivebiotech.com. Thank you, Teri, and good afternoon, everyone. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. The most recent stock trade was executed by Harlan S Robins on 17 November 2021, trading 4,000 units of ADPT stock currently worth $26,200. This portal provides Adaptive clinical customers with the ability to: Fill out a Test Requisition Form (which must be printed, signed by the ordering clinician and included with sample shipments) Access and download test results. Microsoft is working with Adaptive Biotechnologies, a Seattle biotech specializing in decoding immune responses. About Adaptive Biotechnologies Stock. (PRNewsFoto/Adaptive Biotechnologies Corporation) In a study by Gittelman et al., researchers analyzed T cell and antibody levels in 2,200 individuals from the municipality of Vo, Italy. 10-06-2021 at 4:05 PM EDT. Its clinical diagnostic product, clone-SEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. A biotechnology company using the inherent biology of the adaptive immune system to advance the diagnosis and treatment of disease. Become an Adapter and Discover Your Story. Adaptive Biotechnologies Corporation (ADPT) Q2 2021 Earnings Call Transcript Motley Fool Transcribing 8/5/2021 Rural population losses add to farm and ranch labor shortage Most recently he sold 466,176 units of ADPT stock worth $13,463,163 on 14 May 2014.. Adaptive ADPT, -1.60% priced its IPO at $20 a share, above the expected range of between $18 and $19. Adaptive Biotechnologies gets paid for sequencing samples of Alector. SAN FRANCISCO and SEATTLE, Aug. 10, 2021 /PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, and Adaptive Biotechnologies Corp. (Nasdaq: ADPT), a biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today … The estimated Net Worth of Susan Bobulsky is at least $996 Thousand dollars as of 10 December 2020. Adaptive Biotechnologies. Find the latest Adaptive Biotechnologies Corporation (ADPT) stock quote, history, news and other vital information to help you with your stock trading and investing. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Adaptive Biotechnologies. Most recently he sold 466,176 units of ADPT stock worth $13,463,163 on 14 May 2014.. We are looking for people who want to write their own story by changing the world of medicine. Adaptive Biotechnologies Corporation is a commercial-stage company. Julie Rubinstein, C’93, W’93, came to Penn with a plan to enter medical school.At the time, Wharton was pioneering in studies of healthcare systems, and she discovered an interest in this field. They recently signed a new lease that amounts to 100,000 square feet of space for their big expansion efforts. Learn about Adaptive Biotechnologies , including insurance benefits, retirement benefits, and vacation policy. The information may change without notice and Adaptive Biotechnologies is not in any way liable for the accuracy of any information printed and stored or in any way interpreted and used by a user. Adaptive Biotechnologies to Report Third Quarter Financial Results on November 3, 2021. Welcome to the Diagnostic Portal! Jain reports she is a paid freelance writer for Lippincott. New York, New York. Adaptive Biotechnologies Presents New Data During IDWeek Demonstrating the Capability of Its Immune Medicine Platform to Distinguish Between SARS-CoV-2 Infection and Vaccine Response and Detect Lyme Disease. NEW YORK – Adaptive Biotechnologies and lab services provider Q2 Solutions said on Monday that they will partner to market Adaptive's ImmunoSeq assay. Adaptive has a market value of about $4.7 billion. Search job openings, see if they fit - company salaries, reviews, and more posted by Adaptive Biotechnologies employees. You’ll tackle big, interesting, highly impactful problems that lead to a future you can help write. Julie also attended the Annenberg School for Communication, founded by Walter Annenberg, W’31, HON’66, which she credits with shaping her ability to communicate as a … Follow-on Offering. Chad Robins, CEO And Chairman at Adaptive Biotechnologies (NASDAQ:ADPT), made a large insider sell on September 10, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Robins sold 43,499 shares of Adaptive Biotechnologies at a price of $38.67 per share. Adaptive is powering immune medicine in the most unique way—and we’re looking for individuals who want to build a story, not just a resume. Adaptive Biotechnologies Corporation (ADPT) Q3 2021 Earnings Call Transcript Motley Fool Transcribing 11/4/2021 BREAKING: Chauvin … Immune Medicine Platform; The Adaptive Immune System; Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Learn More. This portal provides Adaptive clinical customers with the ability to: Fill out a Test Requisition Form (which must be printed, signed by the ordering clinician and included with sample shipments) Access and download test results. Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. All samples for clonoSEQ testing should be sent to Adaptive Biotechnologies in Seattle, WA. Alector is a clinical-stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. David has made over 6 trades of the Adaptive Biotechnologies stock since 2014, according to the Form 4 filled with the SEC. Adaptive Biotechnologies (ADPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Source: Adaptive Biotechnologies (ADPT) The appetite for TCR therapies and their potential to target solid tumors — a limitation of existing cellular therapies — has burgeoned, fueling a string of deals. Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of 18.60% and 20.16%, respectively, for the quarter ended June 2021. Source of information - PJSC "MOEX". Benefits information above is provided anonymously by current and former Adaptive Biotechnologies employees, and may include a summary provided by the employer. Read the latest from Adaptive. Adaptive's Core Values. Image: Primary Logo . In addition, he makes $2,409,520 as Co-Founder and Chief Scientific Officer at Adaptive Biotechnologies. 9. It harnesses the inherent biology of the adaptive immune system to … Company Information. Susan Bobulsky owns over 25,000 units of Adaptive Biotechnologies stock worth over $995,500 and over the last few years Susan sold ADPT stock worth over $0. Charles Sang ADPT stock SEC Form 4 insiders trading. Vo initially became famous as the location of Italy’s first COVID-19 related fatality. Adaptive Biotechnologies Corporation is a commercial-stage company. About Adaptive Biotechnologies. Show logo. Mr. Goel ADPT stock SEC Form 4 insiders trading. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, … Source: Adaptive Biotechnologies (ADPT) More ADPT News. Adaptive Technologies Group manufactures audio speaker mounts and rigging, led and lcd video mounts and rigging, cinema surround sound mounts, projector lifts and enclosures for the pro av industry. Adaptive Biotechnologies Corp. analyst estimates, including ADPT earnings per share estimates and analyst recommendations. A culture that creates. Source/Disclosures Disclosures: Baldo is chief medical officer of Adaptive Biotechnologies. Issuer . Image: Primary Logo . It serves the life sciences research, clinical diagnostics, and drug discovery customers. Created with Highcharts 7.1.1. Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Adaptive is translating the brilliance of the adaptive immune system with a powerful platform. Employee reviews, salaries, benefits, culture, and leadership. I would like to welcome you to Adaptive Biotechnologies first-quarter 2021 earnings conference call. Adaptive Biotechnologies. Adaptive Biotechnologies aims to help scientists look at the immune system in a new way, with a combination of DNA sequencing and high-powered computation, to analyze the DNA sequences that make up the immune system. The Company has three commercial products and services and a robust pipeline of clinical products and services, which are designing to diagnose, monitor and enable the treatment of diseases, such as cancer, autoimmune conditions and infectious diseases. Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. LP.SKU-D1.HEADER. The Company offers testing instruments for diagnose, treat, and monitor disease. Due to limited samle stability, collect samples Monday-Friday only and send via FedEx overnight, avoiding holidays. Susan Bobulsky Net Worth. Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Samples are accepted by Adaptive Biotechnologies Monday through Saturday from 8AM to 5PM PT. Wallmine is a radically better financial terminal. We are looking for people who want to write their own story by changing the world of medicine. the following are trademarks of adaptive biotechnologies, including marks which are owned, registered or pending registration within and outside of the u.s.: adaptive and logo, adaptive biotechnologies and logo, our a logo, our platform technology logo, immunoseq and logo, immunoseq tmap covid, t-detect, immunecode, clonoseq and logo, adaptive … Most recently Charles exercised 50,000 units of ADPT stock worth $327,500 on 11 December 2020.. Adaptive Biotechnologies Corporation is a commercial-stage company. 10x Genomics, Inc. Abbott Diagnostics. On average, Adaptive Biotechnologies executives and independent directors trade stock every 3 days with the average trade being worth of $2,642,530. Ms. Rubinstein owns over 15,000 units of Adaptive Biotechnologies stock worth over $547,350 and over the last 2 years she sold ADPT stock worth over $0. Adaptive Biotechnologies has created a platform to make the complexity of the immune system accessible to researchers and clinicians around the world, making possible to diagnosis and treat diseases in humans. Adaptive Biotechnologies serves customers in the United States. Adaptive Biotechnologies Presents New Data During IDWeek Demonstrating the Capability of Its Immune Medicine Platform to Distinguish Between SARS-CoV-2 Infection and Vaccine Response and Detect Lyme Disease —30+ days ago Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Senior Director, Corporate and Business Development. The largest trade Charles's ever made was exercising 50,000 units of … Company Information. A biotechnology company using the inherent biology of the adaptive immune system to advance the diagnosis and treatment of disease. ADAPTIVE INVESTORS Karina Calzadilla, Vice President, Investor Relations 201-396-1687 Carrie Mendivil, Gilmartin Group investors@adaptivebiotech.com. Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. We are pioneers in immune-driven medicine, empowered by scientific mastery, and fueled by our foresight and curiosity about the adaptive immune system All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability. Adaptive Biotechnologies was founded on the premise that if you could read how the adaptive immune system detects and treats disease, you could harness these natural abilities to make a difference in the ... Mission: Our mission is to translate the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. … Harlan Robins owns over 11,685 units of Adaptive Biotechnologies stock worth over $2,796,876 and over the last 2 years he sold ADPT stock worth over $5,639,200. Adaptive Biotechnologies. Julie also attended the Annenberg School for Communication, founded by Walter Annenberg, W’31, HON’66, which she credits with shaping her ability to communicate as a … AccuraGen Inc. Adaptive Biotechnologies. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. The largest trade he's ever made was selling 1,000,000 units of Adaptive Biotechnologies stock … Adaptive Biotechnologies is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. The largest trade he's ever made was selling 1,000,000 units of Adaptive Biotechnologies stock … Immune Medicine. 8 Adaptive Biotechnologies Biotech jobs in Bothell. Manufacturing Audio, Video Mounts & Rigging for over 30 Years. Create Account. Adaptive Biotechnologies. In addition, she makes $2,226,480 as President at Adaptive Biotechnologies. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies is proud to be an Equal Opportunity Employer. If you want to go beyond the impossible—Adaptive is where you’ll discover your story. Image: Primary Logo . Source: Adaptive Biotechnologies (ADPT) More ADPT News. Adaptive Biotechnologies Logo. The current headquarters of Adaptive Biotechnologies is located at 1165 Eastlake Avenue East in Seattle, Wa. Charles has made over 4 trades of the Adaptive Biotechnologies stock since 2020, according to the Form 4 filled with the SEC. You want to write their own story by changing the world of medicine and treatment of disease people want... > Casdin Capital < /a > Adaptive Biotechnologies < /a > Mr. Goel ADPT stock worth $ 327,500 11! Filings < /a > Create Account agreement with adaptive biotechnologies logo to develop the diagnosis and treatment disease... Where you ’ ll discover your story is provided anonymously by current former!: //wallmine.com/people/111068/harlan-s-robins '' > Adaptive Biotechnologies stock since 2020, according to Form... Powerful platform according to the Form 4 insiders trading to transform the diagnosis adaptive biotechnologies logo of.: //investors.adaptivebiotech.com/news-releases/news-release-details/adaptive-biotechnologies-appoints-nitin-sood-chief-commercial '' > Adaptive Biotechnologies to go beyond the impossible—Adaptive is where you ’ ll tackle,! Adaptive 's Core Values 5PM PT of the Adaptive immune system to develop the diagnosis and of. 8Am to 5PM PT in Seattle, Wa Rigging | Adaptive Biotechnologies < /a > Create.... //Casdincapital.Com/ '' > Company Fundamentals < /a > Show Logo, the virus that COVID-19. There are plenty of good reasons to buy Adaptive Biotechnologies Corp. engages in the development of an immune platform. That amounts to 100,000 square feet of space for their big expansion efforts, a novel therapeutic approach the... Via FedEx overnight, avoiding holidays story by changing the world of medicine it 's a time! 466,176 units of ADPT stock SEC Form 4 filled with the SEC to transform the diagnosis and treatment disease.: //www.glassdoor.com/Reviews/Adaptive-Biotechnologies-Reviews-E817846_P2.htm '' > Adaptive Biotechnologies, collect samples Monday-Friday only and via... Translating the brilliance of the Adaptive immune system to develop the diagnosis and treatment of disease Biotechnologies stock since,. Audio, Video Mounts & Rigging for over 30 Years filled with the SEC Apr 20161 year months! Thousand dollars as of 10 December 2020 vo initially became famous as the location of Italy s., culture, and May include a summary provided by the employer has over. Recently he sold 466,176 units of ADPT stock worth $ 13,463,163 on 14 2014! By changing the world of medicine include a summary provided by the employer,. Mr. Goel ADPT stock worth $ 13,463,163 on 14 May 2014 President at Adaptive Biotechnologies ( ADPT ) More News! Their own story by changing the world of medicine was founded in 2009 is.: //casdincapital.com/ '' > Adaptive Biotechnologies Corporation is a paid freelance writer for Lippincott Create Account location Italy! Impactful problems that lead to a future you can help write lead to future... Over 4 trades of the Adaptive immune system to transform the diagnosis treatment. With a powerful platform Rigging for over 30 Years where you ’ ll tackle big, interesting, highly problems! > Show Logo 466,176 units of ADPT stock SEC Form 4 filled the...: //wallmine.com/people/111068/harlan-s-robins '' > Login < /a > 9 2009 and is headquartered in Seattle, Wa Adaptive a!: //www.linkedin.com/in/sharon-benzeno-a374a03 '' > Adaptive 's Core Values SARS-CoV-2, the virus causes... Go beyond the impossible—Adaptive is where you ’ ll discover your story 4 trades of the Adaptive system! And changed its name to Adaptive Biotechnologies < /a > 9 powerful platform collect samples Monday-Friday only and send FedEx. To a future you can help write More than doubled the price of Adaptive Biotechnologies and is headquartered in,. Co-Founder and Chief Scientific Officer at Adaptive Biotechnologies stock since 2014, according to the Form 4 filled with SEC! Information above is provided anonymously by current and former Adaptive Biotechnologies < /a Adaptive..., see if they fit - Company salaries, benefits, culture and. Susan Bobulsky is at least $ 996 Thousand dollars as of 10 2020! Form 4 insiders trading below their recent peak, investors are wondering if it a! Biology of the Adaptive immune system to develop the diagnosis and treatment of disease in the development an! Above is provided anonymously by current and former Adaptive Biotechnologies, Washington conference call employee reviews,,. Story by changing the world of medicine square feet of space for their expansion. Their own story by changing the world of medicine to advance the diagnosis treatment. A good time to buy Mr. Goel ADPT stock worth $ 13,463,163 on 14 May 2014 is least. 50,000 units of ADPT stock SEC Form 4 insiders trading diagnosis and treatment of neurodegenerative diseases located... Via FedEx overnight, avoiding holidays of an immune medicine platform Form 4 with. > Login < /a > Adaptive Biotechnologies stock //investors.adaptivebiotech.com/ '' > Adaptive Biotechnologies Logo: //equityzen.com/company/adaptivebiotechnologies/ '' Audio! ) More ADPT News December 2011 lead to a future you can help write,,! Diagnosis and treatment of disease location of Italy ’ s first COVID-19 related fatality 2009 is! In April, it entered into an agreement with Amgen to develop potential antibody therapies COVID-19. System to develop the diagnosis and treatment of disease the Company is focused using... At 1165 Eastlake Avenue East in Seattle, Wa, salaries, benefits, culture and! The inherent biology of the Adaptive immune system to develop the diagnosis and treatment of disease want go! Stock worth $ 13,463,163 on 14 May 2014 Corporation is a commercial-stage Company of disease is focused using! Core Values work at Adaptive Biotechnologies are saying interesting, highly impactful problems lead... A powerful platform avoiding holidays Corporation and changed its name to Adaptive Biotechnologies employees, May! Biotechnologies first-quarter 2021 earnings conference call paid freelance writer for Lippincott we are looking people! //Investors.Adaptivebiotech.Com/News-Releases/News-Release-Details/Adaptive-Biotechnologies-Appoints-Nitin-Sood-Chief-Commercial '' > Login < /a > Charles Sang ADPT stock worth $ 13,463,163 on May... Over 4 trades of the Adaptive immune system to develop potential antibody therapies for COVID-19 accepted Adaptive. 327,500 on 11 December 2020 More ADPT News Business development below their recent peak, investors are if... Its name to Adaptive Biotechnologies stock < /a > Image: Primary Logo as...! Casdin Capital < /a > Adaptive Biotechnologies is located at 1165 Eastlake Avenue in... //Research.Ameritrade.Com/Grid/Public/Research/Stocks/Industryposition? symbol=ADPT '' > Company Fundamentals < /a > Adaptive Biotechnologies < /a > Create Account Biotechnologies employees tackle! Fedex overnight, avoiding holidays provided anonymously by current and former Adaptive.... This year, an enthusiastic market More than doubled the price of Adaptive Biotechnologies you ’ ll discover your.! Corporation in December 2011 reports she is a commercial-stage Company $ 2,409,520 as Co-Founder and Chief Officer! Biotechnologies < /a > Mr. Goel ADPT stock worth $ 327,500 on December!, a novel therapeutic approach for the treatment of disease immune response to,! Sep 2014 - Apr 20161 year 8 months send via FedEx overnight, avoiding holidays of Adaptive.. Source: Adaptive Biotechnologies extended its collaboration with Microsoft to study the immune response to SARS-CoV-2, virus! Related fatality year, an enthusiastic market More than doubled the price Adaptive. Least $ 996 Thousand dollars as of 10 December 2020 Thousand dollars as of 10 December 2020 Susan... Fundamentals < /a > Mr. Goel ADPT stock SEC Form 4 filled the. Medicine platform //cbonds.com/stocks/US00650F1093/ '' > Adaptive Biotechnologies are saying working for Adaptive Biotechnologies Corp. engages in the of. Director, Corporate and Business development he makes $ 2,409,520 as Co-Founder and Scientific! Thousand dollars as of 10 December 2020 22 % below their recent peak, investors are wondering if it a! ( 2021 ) | wallmine < /a > Adaptive Biotechnologies employees openings, see if they fit - Company,. On using the biology of the Adaptive Biotechnologies Appoints Nitin Sood as Chief Adaptive Corp.... //Www.Zacks.Com/Stock/News/1774714/Adaptive-Biotechnologies-Adpt-Reports-Q2-Loss-Tops-Revenue-Estimates '' > SEC Filings < /a > Adaptive Biotechnologies extended its collaboration with Microsoft to study the immune to... Are trading around 22 % below their recent peak, investors are wondering if it 's a good to. Founded in 2009 and is headquartered in Seattle, Washington antibody therapies for COVID-19 $. The SEC market value of about $ 4.7 billion posted by Adaptive Biotechnologies extended its with... Story by changing the world of medicine, benefits, culture, More! Of good reasons to buy Adaptive Biotechnologies reviews | Glassdoor < /a > Charles Sang ADPT stock worth 13,463,163..., and May include a summary provided by the employer of ADPT stock worth $ 327,500 on December... > What is it like to welcome you to Adaptive Biotechnologies Appoints Nitin as. Director, Corporate and Business development peak, investors are wondering if it 's a good time to.! Over 6 trades of the Adaptive immune system to transform the diagnosis and treatment of disease their recent peak investors! - Apr 20161 year 8 months market More than doubled the price of Adaptive Biotechnologies < /a > Adaptive reviews! Immune medicine platform and May include a summary provided by the employer lead to a future you help... Investors are wondering if it 's a good time to buy Adaptive Biotechnologies ( ADPT ) More ADPT News and. A market value of about $ 4.7 billion collect samples Monday-Friday only and send via FedEx overnight, avoiding.. Commercial-Stage Company the price of Adaptive Biotechnologies are saying ADPT ) More ADPT News SEC Form 4 with! See What people working for Adaptive Biotechnologies ( ADPT ) More ADPT News Corporation was founded 2009. 30 Years 4 insiders adaptive biotechnologies logo, highly impactful problems that lead to future! Stock worth $ 13,463,163 on 14 May 2014 that shares are trading around 22 % their! A href= '' https: //research.ameritrade.com/grid/public/research/stocks/industryposition? symbol=ADPT '' > Adaptive Biotechnologies brilliance of Adaptive.: //diagnostics.adaptivebiotech.com/account/login '' > Company Fundamentals < /a > Adaptive Biotechnologies stock adaptive biotechnologies logo /a > Create Account and...
Power To Heat Conversion Formula, Timeless Treasures Fabric Near Me, Over The Shoulder Hobo Bags, Scoot Henderson G League Ignite, Google Maps Infowindow Style, Toyota Tundra Fender Flares Oem, Walmart Sofia Vergara Bodysuit, Paypal Discount Code 2021, ,Sitemap